Skip to main content
SpringerLink
Log in

Biological markers in alcoholism

  • Conference paper
Book cover Addiction Mechanisms, Phenomenology and Treatment

Summary

Alcohol biomarkers include tests indicative of acute or chronic alcohol consumption (state markers), and markers of a genetic predisposition to develop alcohol dependence after chronic exposure (trait markers). While a comprehensive trait marker for alcohol dependence has not been identified, a number of successful state markers for monitoring drinking status are used clinically. These tests provide direct or indirect ways to estimate the amounts of alcohol consumed and the duration of ingestion, and to detect any harmful effects on body functions resulting from long-term misuse. The most obvious method to prove recent drinking is by demonstrating the presence of ethanol in body fluids or breath, but, because ethanol is cleared fairly rapidly from the body, this method is limited to detect only very recent drinking. Measurement of urinary 5-hydroxytryptophol or ethyl glucuronide provide more sensitive methods to disclose recent drinking, because their washout constants are much longer than for ethanol. The liver functions test (GGT, AST and ALT in serum) and the mean corpuscular volume of erythrocytes (MCV) are among the standard diagnostic tools used to identify chronic alcohol exposure. The main disadvantage with these measures is that they have low sensitivity for recent excessive intake, and that raised levels may result from several causes besides heavy drinking, implying a low specificity for alcohol. Carbohydrate-deficient transferrin (CDT), which refers to changes in the carbohydrate composition of serum transferrin, is a more specific marker for identifying excessive alcohol consumption and monitoring abstinence during outpatient treatment. The alcohol biomarkers improves knowledge of drinking patterns in both individuals and populations, and they are also valuable tools for the objective evaluation of treatment efforts. Alcohol markers have, for example, found uses in early identification of at-risk and harmful drinking, and they help to monitor abstinence and relapse in response to outpatient treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aertgeerts B, Buntinx F, Ansoms S, Fevery J (2001) Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population. Br J Gen Pract 51: 206–217

    PubMed  CAS  Google Scholar 

  • Agarwal DP (1997) Molecular genetic aspects of alcohol metabolism and alcoholism. Pharmacopsychiatry 30: 79–84

    Article  PubMed  CAS  Google Scholar 

  • Allen JP, Litten RZ, Anton RF, Cross GM (1994) Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res 18: 799–812

    Article  PubMed  CAS  Google Scholar 

  • Arndt T (2001) Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 47: 13–27

    PubMed  CAS  Google Scholar 

  • Aubin HJ, Laureaux C, Zerah F, Tilikete S, Vernier F, Vallat B, Barrucand D (1998) Joint influence of alcohol, tobacco, and coffee on biological markers of heavy drinking in alcoholics. Biol Psychiatry 44: 638–643

    Article  PubMed  CAS  Google Scholar 

  • Beck O, Helander A, Carlsson S, Borg S (1995) Changes in serotonin metabolism during treatment with the aldehyde dehydrogenase inhibitors disulfiram and cyanamide. Pharmacol Toxicol 77: 323–326

    Article  PubMed  CAS  Google Scholar 

  • Bendtsen P, Jones AW, Helander A (1998) Urinary excretion of methanol and 5-hydroxytryptophol as biochemical markers of recent drinking in the hangover state. Alcohol Alcohol 33: 431–438

    PubMed  CAS  Google Scholar 

  • Bendtsen P, Hultberg J, Carlsson M, Jones AW (1999) Monitoring ethanol exposure in a clinical setting by analysis of blood, breath, saliva, and urine. Alcohol Clin Exp Res 23: 1446–1451

    Article  PubMed  CAS  Google Scholar 

  • Borg S, Helander A, Voltaire Carlsson A, Högström-Brandt A-M (1995) Detection of relapses in alcohol dependent patients using carbohydrate-deficient transferrin: improvement with individualized reference levels during long-term monitoring. Alcohol Clin Exp Res 19: 961–963

    Article  PubMed  CAS  Google Scholar 

  • Carrigan TD, Field H, Illingworth RN, Gaffney P, Hamer DW (2000) Toxicological screening in trauma. J Accid Emerg Med 17: 33–37

    Article  PubMed  CAS  Google Scholar 

  • Cherpitel CJ (1997) Alcohol and violence-related injuries in the emergency room. Rec Dev Alcohol 13: 105–118

    Article  CAS  Google Scholar 

  • Cherpitel CJ, Giesbrecht N, Macdonald S (1999) Alcohol and injury: a comparison of emergency room populations in two Canadian provinces. Am J Drug Alcohol Abuse 25: 743–759

    Article  PubMed  CAS  Google Scholar 

  • Chick J, Kreitman N, Plant M (1981) Mean cell volume and gammaglutamyltranspeptidase as markers of drinking in working men. Lancet i: 1249–1251

    Article  Google Scholar 

  • Coccini T, Castoldi AF, Gandini C, Randine G, Vittadini G, Baiardi P, Manzo L (2002) Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender. Alcohol Alcohol 37: 566–572

    PubMed  CAS  Google Scholar 

  • Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26: 332–339

    Article  PubMed  CAS  Google Scholar 

  • Dahl H, Stephanson N, Beck O, Helander A (2002) Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide. J Anal Toxicol 26: 201–204

    PubMed  CAS  Google Scholar 

  • Davis VE, Brown H, Huff JA, Cashaw JL (1967) The alteration of serotonin metabolism to 5-hydroxytryptophol by ethanol ingestion in man. J Lab Clin Med 69: 132–140

    PubMed  CAS  Google Scholar 

  • DiMartini A, Day N, Lane T, Beisler AT, Dew MA, Anton R (2001) Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res 25: 1729–1733

    Article  PubMed  CAS  Google Scholar 

  • D’Onofrio G, Degutis LC (2002) Preventive care in the emergency department: screening and brief intervention for alcohol problems in the emergency department: a systematic review. Acad Emerg Med 9: 627–638

    Article  PubMed  Google Scholar 

  • Dorafshar AH, O’Boyle DJ, McCloy RF (2002) Effects of a moderate dose of alcohol on simulated laparoscopic surgical performance. Surg Endosc 16: 1753–1758

    Article  PubMed  CAS  Google Scholar 

  • Eggers V, Tio J, Neumann T, Pragst F, Muller C, Schmidt LG, Kox WJ, Spies CD (2002) Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Med 28: 1475–1482

    Article  PubMed  Google Scholar 

  • Enoch MA, Goldman D (2001) The genetics of alcoholism and alcohol abuse. Curr Psychiatry Rep 3: 144–151

    Article  PubMed  CAS  Google Scholar 

  • Freeze HH (2001) Update and perspectives on congenital disorders of glycosylation. Glycobiology 11: 129R–143R

    Article  PubMed  CAS  Google Scholar 

  • Fuller RK, Lee KK, Gordis E (1988) Validity of self-report in alcoholism research: results of a Veterans Administration cooperative study. Alcohol Clin Exp Res 12: 201–205

    Article  PubMed  CAS  Google Scholar 

  • Gelernter J, Goldman D, Risch N (1993) The Al allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. JAMA 269: 1673–1677

    Article  PubMed  CAS  Google Scholar 

  • George S, Braithwaite RA (1995) An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening. Addiction 90: 967–970

    Article  PubMed  CAS  Google Scholar 

  • Hagan RL, Helander A (1997) Urinary 5-hydroxytryptophol following acute ethanol consumption: clinical evaluation and potential aviation applications. Aviat Space Environ Med 68: 30–34

    PubMed  CAS  Google Scholar 

  • Hearne R, Connolly A, Sheehan J (2002) Alcohol abuse: prevalence and detection in a general hospital. J R Soc Med 95: 84–87

    Article  PubMed  Google Scholar 

  • Helander A (1999) Absolute or relative measurement of carbohydrate-deficient transferrin in serum? Experiences with three immunological assays. Clin Chem 45: 131–135

    PubMed  CAS  Google Scholar 

  • Helander A, Carlsson S (1996) Carbohydrate-deficient transferrin and gamma-glutamyl transferase levels during disulfiram therapy. Alcohol Clin Exp Res 20: 1202–1205

    Article  PubMed  CAS  Google Scholar 

  • Helander A, Eriksson CJ (2002) Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcohol Clin Exp Res 26: 1070–1077

    Article  PubMed  Google Scholar 

  • Helander A, Beck O, Wennberg M, Wikström T, Jacobsson G (1991) Determination of urinary 5-hydroxyindole-3-acetic acid by high-performance liquid chromatography with electrochemical detection and direct sample injection. Anal Biochem 196: 170–173

    Article  PubMed  CAS  Google Scholar 

  • Helander A, Wikström T, Löwenmo C, Jacobsson G, Beck O (1992) Urinary excretion of 5-hydroxyindole-3-acetic acid and 5-hydroxytryptophol after oral loading with serotonin. Life Sci 50: 1207–1213

    Article  PubMed  CAS  Google Scholar 

  • Helander A, Beck O, Jacobsson G, Löwenmo C, Wikström T (1993) Time course of ethanol-induced changes in serotonin metabolism. Life Sci 53: 847–855

    Article  PubMed  CAS  Google Scholar 

  • Helander A, Beck O, Jones AW (1995) Distinguishing ingested ethanol from microbial formation by analysis of urinary 5-hydroxytryptophol and 5-hydroxyindoleacetic acid. J Forens Sci 40: 95–98

    CAS  Google Scholar 

  • Helander A, Beck O, Boysen L (1995) 5-Hydroxytryptophol conjugation in man: influence of alcohol consumption and altered serotonin turnover. Life Sci 56: 1529–1534

    Article  PubMed  CAS  Google Scholar 

  • Helander A, Beck O, Jones AW (1996a) Laboratory testing for recent alcohol consumption: comparison of ethanol, methanol, and 5-hydroxytryptophol. Clin Chem 42: 618–624

    PubMed  CAS  Google Scholar 

  • Helander A, Voltaire Carlsson A, Borg S (1996b) Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: complementary markers of excessive alcohol consumption. Alcohol Alcohol 31: 101–107

    PubMed  CAS  Google Scholar 

  • Helander A, von Wachenfeldt J, Hiltunen A, Beck O, Liljeberg P, Borg S (1999) Comparison of urinary 5-hydroxytryptophol, breath ethanol, and self-report for detection of recent alcohol use during outpatient treatment: a study on methadone patients. Drug Alcohol Depend 56: 33–38

    Article  PubMed  CAS  Google Scholar 

  • Helander A, Eriksson G, Stibler H, Jeppsson J-O (2001) Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 47: 1225–1233

    PubMed  CAS  Google Scholar 

  • Hermansson U, Knutsson A, Rönnberg S, Brandt L (1998) Feasibility of brief intervention in the workplace for the detection and treatment of excessive alcohol consumption. Int J Occup Environ Health 4: 71–78

    PubMed  CAS  Google Scholar 

  • Hermansson U, Helander A, Huss A, Brandt L, Rönnberg S (2000) The Alcohol Use Disorders Identification Test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res 24:180–187

    Article  PubMed  CAS  Google Scholar 

  • Higuchi S, Matsushita S, Murayama M, Takagi S, Hayashida M (1995) Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 152: 1219–1221

    PubMed  CAS  Google Scholar 

  • Hoffman PL, Glanz J, Tabakoff B (2002) Platelet adenylyl cyclase activity as a state or trait marker in alcohol dependence: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcohol Clin Exp Res 26: 1078–1087

    Article  PubMed  CAS  Google Scholar 

  • Holt S, Stewart IC, Dixon JM, Elton RA, Taylor TV, Little K (1980) Alcohol and the emergency service patient. Br Med J 281: 638–640

    Article  PubMed  CAS  Google Scholar 

  • Huseby NE, Bjordal E, Nilssen O, Barth T (1997) Utility of biological markers during outpatient treatment of alcohol-dependent subjects: carbohydrate-deficient transferrin responds to moderate changes in alcohol consumption. Alcohol Clin Exp Res 21: 1343–1346

    PubMed  CAS  Google Scholar 

  • Iffland R (1996) New ways to use biochemical indicators of alcohol abuse to regrant licences in a fairer manner after drunken driving in Germany. Alcohol Alcohol 31: 619–620

    PubMed  CAS  Google Scholar 

  • Irwin M, Baird S, Smith TL, Schuckit M (1988) Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program. Am J Psychiatry 145: 595–599

    PubMed  CAS  Google Scholar 

  • Jaakonmaki PI, Knox KL, Horning EC, Horning MG (1967) The characterization by gas-liquid chromatography of ethyl β-D-glucosiduronic acid as a metabolite of ethanol in rat and man. Eur J Pharmacol 1: 63–70

    Article  PubMed  CAS  Google Scholar 

  • Jeppsson J-O, Kristensson H, Fimiani C (1993) Carbohydrate deficient transferrin quantitated by HPLC to determine heavy consumption of alcohol. Clin Chem 39: 2115–2120

    PubMed  CAS  Google Scholar 

  • Jones AW (1995) Measuring ethanol in saliva with the QED enzymatic test device: comparison of results with blood and breath-alcohol concentration. J Anal Toxicol 19: 169–173

    PubMed  CAS  Google Scholar 

  • Jones AW, Schuberth J (1989) Computer-aided headspace gas chromatography applied to blood-alcohol analysis: importance of on-line process control. J Forens Sci 34: 1116–1127

    CAS  Google Scholar 

  • Jones AW, Helander A (1998) Changes in the concentrations of ethanol, methanol and metabolites of serotonin in two successive urinary voids from drinking drivers. Forensic Sci Int 93: 127–134

    Article  PubMed  CAS  Google Scholar 

  • Jones AW, Hylén L, Svensson E, Helander A (1999) Storage of specimens at 4 degrees C or addition of sodium fluoride (1 %) prevents formation of ethanol in urine inoculated with Candida albicans. J Anal Toxicol 23: 333–336

    PubMed  CAS  Google Scholar 

  • Kristenson H, Jeppsson J-O (1998) Drunken driver examinations. CD-transferrin is a valuable marker of alcohol consumption. Läkartidningen 95: 1429–1430

    Google Scholar 

  • Kristenson H, Österling A, Nilsson JÄ, Lindgärde F (2002) Prevention of alcohol-related deaths in middle-aged heavy drinkers. Alcohol Clin Exp Res 26: 478–484

    Article  PubMed  Google Scholar 

  • Landberg E, Påhlsson P, Lundblad A, Arnetorp A, Jeppsson J-O (1995) Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. Biochem Biophys Res Commun 210: 267–274

    Article  PubMed  CAS  Google Scholar 

  • Martin MJ, Heymann C, Neumann T, Schmidt L, Soost F, Mazurek B, Bohm B, Marks C, Helling K, Lenzenhuber E, Muller C, Kox WJ, Spies CD (2002) Preoperative evaluation of chronic alcoholics assessed for surgery of the upper digestive tract. Alcohol Clin Exp Res 26: 836–840

    Article  PubMed  CAS  Google Scholar 

  • McQuade WH, Levy SM, Yanek LR, Davis SW, Liepman MR (2000) Detecting symptoms of alcohol abuse in primary care settings. Arch Fam Med 9: 814–821

    Article  PubMed  CAS  Google Scholar 

  • Meerkerk GJ, Njoo KH, Bongers IM, Trienekens P, van Oers JA (1998) The specificity of the CDT assay in general practice: the influence of common chronic diseases and medication on the serum CDT concentration. Alcohol Clin Exp Res 22: 908–913

    PubMed  CAS  Google Scholar 

  • Meerkerk GJ, Njoo KH, Bongers IM, Trienekens P, van Oers JA (1999) Comparing the diagnostic accuracy of carbohydrate-deficient transferrin, gamma-glutamyl-transferase, and mean cell volume in a general practice population. Alcohol Clin Exp Res 23: 1052–1059

    Article  PubMed  CAS  Google Scholar 

  • Midanik LT (1988) Validity of self-reported alcohol use: a literature review and assessment. Br J Addict 83: 1019–1030

    Article  PubMed  CAS  Google Scholar 

  • Mitchell C, Simpson D, Chick J (1997) Carbohydrate deficient transferrin in detecting relapse in alcohol dependence. Drug Alcohol Depend 48: 97–103

    Article  PubMed  CAS  Google Scholar 

  • Nilssen O, Førde OH (1994) Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø study. Am J Epidemiol 139: 787–792

    PubMed  CAS  Google Scholar 

  • Nishikawa M, Tsuchihashi H, Miki A, Katagi M, Schmitt G, Zimmer H, Keller T, Aderjan R (1999) Determination of ethyl glucuronide, a minor metabolite of ethanol, in human serum by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 726: 105–110

    Article  PubMed  CAS  Google Scholar 

  • Peter J, Unverzagt C, Engel WD, Renauer D, Seidel C, Hosel W (1998) Identification of carbohydrate deficient transferrin forms by MALDI-TOF mass spectrometry and lectin ELISA. Biochim Biophys Acta 1380: 93–101

    Article  PubMed  CAS  Google Scholar 

  • Ragland DR, Krause N, Greiner BA, Holman BL, Fisher JM, Cunradi CB (2002) Alcohol consumption and incidence of workers’ compensation claims: a 5-year prospective study of urban transit operators. Alcohol Clin Exp Res 26: 1388–1394

    PubMed  Google Scholar 

  • Ratsma JE, Van Der Stelt O, Gunning WB (2002) Neurochemical markers of alcoholism vulnerability in humans. Alcohol Alcohol 37: 522–533

    PubMed  CAS  Google Scholar 

  • Reid MC, Fiellin DA, O’Connor PG (1999) Hazardous and harmful alcohol consumption in primary care. Arch Intern Med 159: 1681–1689

    Article  PubMed  CAS  Google Scholar 

  • Rosalki SB, Rau D (1972) Serum gamma-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 39: 41–47

    Article  PubMed  CAS  Google Scholar 

  • Rosman AS, Basu P, Galvin K, Lieber CS (1995) Utility of carbohydrate-deficient transferrin as a marker of relapse in alcoholic patients. Alcohol Clin Exp Res 19: 611–616

    Article  PubMed  CAS  Google Scholar 

  • Schmitt G, Aderjan R, Keller T, Wu M (1995) Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J Anal Toxicol 19: 91–94

    PubMed  CAS  Google Scholar 

  • Schmitt G, Droenner P, Skopp G, Aderjan R (1997) Ethyl glucuronide concentration in serum of human volunteers, teetotalers, and suspected drinking drivers. J Forensic Sci 42: 1099–1102

    PubMed  CAS  Google Scholar 

  • Schuckit MA (2000) Genetics of the risk for alcoholism. Am J Addict 9: 103–112

    Article  PubMed  CAS  Google Scholar 

  • Seidl S, Wurst FM, Alt A (2001) Ethyl glucuronide — a biological marker for recent alcohol consumption. Addict Biol 6: 205–212

    Article  PubMed  CAS  Google Scholar 

  • Shepherd J (1994) Violent crime: the role of alcohol and new approaches to the prevention of injury. Alcohol Alcohol 29: 5–10

    PubMed  CAS  Google Scholar 

  • SmoUe KH, Hofmann G, Kaufmann P, Lueger A, Brunner G (1999) Q.E.D. Alcohol test: a simple and quick method to detect ethanol in saliva of patients in emergency departments. Comparison with the conventional determination in blood. Intensive Care Med 25: 492–495

    Article  Google Scholar 

  • Spies CD, Nordmann A, Brummer G, Marks C, Conrad C, Berger G, Runkel N, Neumann T, Müller C, Rommelspacher H, Specht M, Hannemann L, Striebel HW, Schaffartzik W (1996) Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol Scand 40: 649–656

    Article  PubMed  CAS  Google Scholar 

  • Spies CD, Kissner M, Neumann T, Blum S, Voigt C, Funk T, Runkel N, Pragst F (1998) Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit tay in traumatized men. Alcohol Alcohol 33: 661–669

    PubMed  CAS  Google Scholar 

  • Spies CD, Herpell J, Beck O, Muller C, Pragst F, Borg S, Helander A (1999) The urinary ratio of 5-hydroxytryptophol to 5-hydroxyindole-3-acetic acid in surgical patients with chronic alcohol misuse. Alcohol 17: 19–27

    Article  PubMed  CAS  Google Scholar 

  • Staak M, Iffland R (1992) Alcoholism detection markers in blood samples of road users. Arukoru Kenkyuto Yakubutsu Izon 27: 42–49

    CAS  Google Scholar 

  • Stephanson N, Dahl H, Helander A, Beck O (2002) Direct quantification of ethyl glucu-ronide in clinical urine samples by liquid chromatography-mass spectrometry. Ther Drug Monit 24: 645–651

    Article  PubMed  CAS  Google Scholar 

  • Stibler H (1991) Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37: 2029–2037

    PubMed  CAS  Google Scholar 

  • Svensson S, Some M, Lundsjö A, Helander A, Cronholm T, Höög J-O (1999) Activities of human alcohol dehydrogenases in the metabolic pathways of ethanol and serotonin. Eur J Biochem 262: 324–329

    Article  PubMed  CAS  Google Scholar 

  • Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H (1998) Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 27: 438–443

    Article  PubMed  CAS  Google Scholar 

  • Tønnesen H (1999) The alcohol patient and surgery. Alcohol Alcohol 34: 148–152

    PubMed  Google Scholar 

  • Tønnesen H, Carstensen M, Maina P (1999) Is carbohydrate deficient transferrin a useful marker of harmful alcohol intake among surgical patients? Eur J Surg 165: 522–527

    Article  PubMed  Google Scholar 

  • Voltaire A, Beck O, Borg S (1992) Urinary 5-hydroxytryptophol: a possible marker of recent alcohol consumption. Alcohol Clin Exp Res 16: 281–285

    Article  PubMed  CAS  Google Scholar 

  • Voltaire Carlsson A, Hiltunen AJ, Beck O, Stibler H, Borg S (1993) Detection of relapses in alcohol-dependent patients: comparison of carbohydrate-deficient transferrin in serum, 5-hydroxytryptophol in urine, and self-reports. Alcohol Clin Exp Res 17:703–708

    Article  Google Scholar 

  • Wiese JG, Shlipak MG, Browner WS (2000) The alcohol hangover. Ann Intern Med 132: 897–902

    PubMed  CAS  Google Scholar 

  • Yesavage JA, Dolhert N, Taylor JL (1994) Flight simulator performance of younger and older aircraft pilots: effects of age and alcohol. J Am Geriatr Soc 42: 577–582

    PubMed  CAS  Google Scholar 

  • Yokoyama A, Muramatsu T, Omori T, Yokoyama T, Matsushita S, Higuchi S, Maruyama K, Ishii H (2001) Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22: 433–439

    Article  PubMed  CAS  Google Scholar 

  • Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561–577

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Neuroscience, Karolinska Institutet & Hospital, Stockholm, Sweden

    Dr. A. Helander

  2. Alcohol Laboratory, Karolinska Hospital, SE-171 76, Stockholm, Sweden

    Dr. A. Helander

Authors
  1. Dr. A. Helander
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, A-6020, Innsbruck, Austria

    W. W. Fleischhacker

  2. MRC Cyclotron Unit, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK

    D. J. Brooks

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Wien

About this paper

Cite this paper

Helander, A. (2003). Biological markers in alcoholism. In: Fleischhacker, W.W., Brooks, D.J. (eds) Addiction Mechanisms, Phenomenology and Treatment. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0541-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0541-2_2

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-01316-8

  • Online ISBN: 978-3-7091-0541-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation